Friday, September 30, 2022


Biotechnology News Magazine

Jacob Katz Named Senior Director of Sales & Product Management at RIVANNA®

Experienced Healthcare Marketing Expert Leads Commercial Strategy and Growth

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

RIVANNA®, developers of world-first, imaging-based medical solutions, has appointed Jacob Katz as the senior director of sales and product management. Jacob Katz is responsible for strategic marketing planning, managing commercialization, and driving market adoption. Further, he works to optimize distribution partnerships and inform product development strategy through customer insights.

Before joining RIVANNA, Katz was director of marketing strategy for Medline Industries, Inc. In that position, he led a multi-channel marketing strategy for a product portfolio exceeding 40 brands, including brands generating more than $100 million in revenue. Katz also served as a product manager for Medline, during which time he tripled advanced wound treatment sales in less than 10 years.

Katz holds a Master of Business Administration from Kellogg Graduate School of Management at Northwestern University, where he graduated with distinction.

“I am impressed with RIVANNA’s impactful technology, brilliant leadership team and stellar product development pipeline,” Katz comments. “I am thrilled to help RIVANNA reach its potential in financial performance and clinical impact.”

RIVANNA has innovative products under development that address multibillion-dollar market segments. These include a rapid, radiation-free fracture detection system developed in partnership with The Biomedical Advanced Research and Development Authority and an automated 3D image-guided system designed to deliver chronic pain relief safely and effectively without the need for addictive opioids.

“We welcome Jacob’s significant sales, strategic marketing and product management experience as we move forward with commercialization and rollout of our new technologies,” comments Will Mauldin, PhD, RIVANNA co-founder and CEO. “Jacob combines a wealth of successful medical device commercialization experience with strong educational business training from a highly regarded MBA program. We are delighted to have him join our team.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine